Dr George R Simon, Professor of Medicine and Section Chief, Translational Research, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas talks about the SPORE programme for controlling lung cancer incidence and explains the role and impact of DNA repair pathways in therapeutic efficacy, in an interview with Viveka Roychowdhury.
India has a high burden of lung cancer. What are the causes specific to the country for this growing incidence?
About 1.8-2 million new lung cancer cases are estimated to occur globally, 6.9 per cent of which are from India. Globally, the disease is one of the commonest cancers and cause of cancer related deaths, and in India, lung cancer is the commonest cancer and cause of cancer related mortality in men.
Factors that are known to contribute to the growing incidence of lung cancer in India include smoking, bidi smoking, exposure to biomass fuel and environmental pollution. The incidence and pattern of lung cancer tend to differ with geographic region and ethnicity and largely reflect the prevalence and pattern of smoking in the country.
As the Section Chief, Translational Research, Department of Thoracic/Head and Neck Medical Oncology, what are the most promising areas of research to treat lung cancer?
Today, most research on lung cancer is focussed on areas of prevention, early detection and treatment. Promising lung cancer treatment options that have emerged include video assisted thoracic surgery (VATS) to treat small lung tumours, image guided radiation therapy (IGRT), newer combinations of chemotherapy drugs, immunotherapy and targeted therapy. Several new and exciting targeted therapies and immunotherapies have been approved in the last two years. These drugs have dramatically improved the lung cancer landscape. Newer treatment strategies evolve as resistance develops to existing treatments. Understanding these resistance treatments leads to the development of newer drugs to mitigate emerging mechanisms of resistance.
Could you give us more details of SPORE, the Specialized Program of Research Excellence programme and what hope does it offer lung cancer patients?
Denne historien er fra June 16, 2017-utgaven av Express Pharma.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra June 16, 2017-utgaven av Express Pharma.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation
